Expression of concern: "Adelmidrol, a Palmitoylethanolamide Analogue, as a New PharmacologicalTreatment for the Management of Inflammatory Bowel Disease" [Mol. Pharmacol. 2016; 90: 549-561] by Cordaro M, Impellizzeri D, Gugliandolo E, et al
ReviewOther animals
- Design
- Review
- Subjects
- Not stated in the abstract
- Dose used in the study
- Not stated in the abstract
- Duration
- Not stated in the abstract
- What was measured
- Not applicable; this is a publisher's expression of concern notice, not a study report.
What the authors reported
The journal published an expression of concern for the 2016 paper "Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease" by Cordaro M, Impellizzeri D, Gugliandolo E et al (PMID 27625036). The PubMed record gives no further detail on the reasons for the concern.
Limits of this study
This is an administrative notice, not a new study. Readers of the original 2016 paper should treat its findings as under review by the journal until the concern is resolved. No conflict or funding information is stated.
Source
PubMed 42062010 · doi:10.1016/j.molpha.2026.100109
Entry checked against the PubMed record; the notice has no abstract on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.